BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1243 related articles for article (PubMed ID: 16008943)

  • 1. [Expression of melanoma antigen gene in urinary transitional cell carcinomas].
    Geng L; Yu LZ; Du P; Ma M; Na YQ
    Zhonghua Wai Ke Za Zhi; 2005 May; 43(10):667-71. PubMed ID: 16008943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression profile of cancer-testis genes in transitional cell carcinoma of the bladder.
    Yin B; Liu G; Wang XS; Zhang H; Song YS; Wu B
    Urol Oncol; 2012; 30(6):886-92. PubMed ID: 21396841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression.
    Quentin T; Schlott T; Korabiowska M; Käthei N; Zöller G; Glaser F; Kunze E
    Anticancer Res; 2004; 24(5A):2745-56. PubMed ID: 15517881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate stem cell antigen predicts tumour recurrence in superficial transitional cell carcinoma of the urinary bladder.
    Elsamman E; Fukumori T; Kasai T; Nakatsuji H; Nishitani MA; Toida K; Ali N; Kanayama HO
    BJU Int; 2006 Jun; 97(6):1202-7. PubMed ID: 16686711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered mRNA expression of the Rb and p16 tumor suppressor genes and of CDK4 in transitional cell carcinomas of the urinary bladder associated with tumor progression.
    Quentin T; Henke C; Korabiowska M; Schlott T; Zimmerman B; Kunze E
    Anticancer Res; 2004; 24(2B):1011-23. PubMed ID: 15161057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of melanoma antigen tumor antigens occurs early in lung carcinogenesis.
    Jang SJ; Soria JC; Wang L; Hassan KA; Morice RC; Walsh GL; Hong WK; Mao L
    Cancer Res; 2001 Nov; 61(21):7959-63. PubMed ID: 11691819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MAGE-12 and MAGE-6 are frequently expressed in malignant melanoma.
    Gibbs P; Hutchins AM; Dorian KT; Vaughan HA; Davis ID; Silvapulle M; Cebon JS
    Melanoma Res; 2000 Jun; 10(3):259-64. PubMed ID: 10890380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is quantitative real-time RT-PCR an adjunct to immunohistochemistry for the evaluation of ErbB2 status in transitional carcinoma of the bladder?
    Amsellem-Ouazana D; Bièche I; Molinié V; Elie C; Vieillefond A; Tozlu S; Botto H; Debré B; Lidereau R
    Eur Urol; 2006 Jun; 49(6):1035-42; discussion 1042-3. PubMed ID: 16466848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance.
    Yoshida N; Abe H; Ohkuri T; Wakita D; Sato M; Noguchi D; Miyamoto M; Morikawa T; Kondo S; Ikeda H; Nishimura T
    Int J Oncol; 2006 May; 28(5):1089-98. PubMed ID: 16596224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MAGE-A gene expression pattern in primary breast cancer.
    Otte M; Zafrakas M; Riethdorf L; Pichlmeier U; Löning T; Jänicke F; Pantel K
    Cancer Res; 2001 Sep; 61(18):6682-7. PubMed ID: 11559535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) in bladder transitional cell carcinoma.
    Ham WS; Lee JH; Yu HS; Choi YD
    Urology; 2008 Oct; 72(4):921-6. PubMed ID: 18387660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative detection of cytokeratin 20 mRNA expression in bladder carcinoma by real-time reverse transcriptase-polymerase chain reaction.
    Christoph F; Müller M; Schostak M; Soong R; Tabiti K; Miller K
    Urology; 2004 Jul; 64(1):157-61. PubMed ID: 15245962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of NY-ESO-1 and LAGE-1 expression in bladder cancer and evidence of a new NY-ESO-1 T-cell epitope in a patient with bladder cancer.
    Sharma P; Gnjatic S; Jungbluth AA; Williamson B; Herr H; Stockert E; Dalbagni G; Donat SM; Reuter VE; Santiago D; Chen YT; Bajorin DF; Old LJ
    Cancer Immun; 2003 Dec; 3():19. PubMed ID: 14680360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In situ gene expression of urokinase-type plasminogen activator and its receptor in transitional cell carcinoma of the human bladder.
    Bhuvarahamurthy V; Schroeder J; Denkert C; Kristiansen G; Schnorr D; Loening SA; Jung K; Staack A
    Oncol Rep; 2004 Oct; 12(4):909-13. PubMed ID: 15375521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of MAGE-A1 and MAGE-A3 genes in human salivary gland carcinomas.
    Liu J; Wang G; Okutomi T; Chen Z
    Chin Med J (Engl); 2003 Jun; 116(6):897-900. PubMed ID: 12877803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of apoptosis inhibitor gene Livin in bladder transitional cell carcinoma and clinical implication thereof].
    Song T; Hong BF; Gao JP; Cai W; Wang CY
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(12):806-7. PubMed ID: 17565859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of melanoma-associated antigens in oral squamous cell carcinoma.
    Ries J; Vairaktaris E; Mollaoglu N; Wiltfang J; Neukam FW; Nkenke E
    J Oral Pathol Med; 2008 Feb; 37(2):88-93. PubMed ID: 18197853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.
    Bowles L; Bialkowska-Hobrzanska H; Bukala B; Nott L; Razvi H
    Can J Urol; 2004 Dec; 11(6):2438-44. PubMed ID: 15636669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transitional cell carcinomas and nonurothelial carcinomas of the urinary bladder differ in the promoter methylation status of the caveolin-1, hDAB2IP and p53 genes, but not in the global methylation of Alu elements.
    Kunze E; Von Bonin F; Werner C; Wendt M; Schlott T
    Int J Mol Med; 2006 Jan; 17(1):3-13. PubMed ID: 16328005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of family A melanoma antigen in human gastric carcinoma.
    Jung EJ; Kim MA; Lee HS; Yang HK; Lee YM; Lee BL; Kim WH
    Anticancer Res; 2005; 25(3B):2105-11. PubMed ID: 16158951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 63.